TY - JOUR KW - Adjuvants, Immunologic KW - Adolescent KW - Adult KW - Aged KW - Female KW - Humans KW - Lepromin KW - leprosy KW - Levamisole KW - Male KW - Middle Aged AU - Arora S K AU - Singh G AU - Sen P C AB -

Eleven cases of borderline-borderline leprosy were subjected to levamisole therapy for 3 months. Levamisole was given 150 mg/day on three consecutive days every fortnight along with dapsone (DDS). Immuno-stimulation was assessed by lepromin test using Lepromin-A supplied by W.H.O. containing 4.0 X 10(7) bacilli per milli litre. It was found that there was statistically significant change in lepromin reaction after levamisole therapy.

BT - Indian journal of leprosy C1 - http://www.ncbi.nlm.nih.gov/pubmed/3839822?dopt=Abstract CN - Infolep Library - available DA - 1985 Jan-Mar IS - 1 J2 - Indian J Lepr LA - eng N2 -

Eleven cases of borderline-borderline leprosy were subjected to levamisole therapy for 3 months. Levamisole was given 150 mg/day on three consecutive days every fortnight along with dapsone (DDS). Immuno-stimulation was assessed by lepromin test using Lepromin-A supplied by W.H.O. containing 4.0 X 10(7) bacilli per milli litre. It was found that there was statistically significant change in lepromin reaction after levamisole therapy.

PY - 1985 SP - 22 EP - 6 T2 - Indian journal of leprosy TI - Immuno-stimulatory effect of levamisole in borderline leprosy cases. VL - 57 SN - 0254-9395 ER -